CervoMed Inc. Prepaid Expense and Other Assets, Current
CervoMed Inc. (CRVO) had Prepaid Expense and Other Assets, Current of $733.72 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-07
- 2026-06-30: Prepaid Expense and Other Assets, Current $733.72K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $1.70M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $1.27M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $1.69M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $733.72K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $1.70M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $1.27M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $1.69M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $1.96M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $1.70M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $1.91M 10-K · filed 2026-03-13 |
| 2024-09-30 | $1.89M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $2.24M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $1.35M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.26M 10-K · filed 2025-03-17 |
| 2023-09-30 | $1.42M 10-Q · filed 2023-11-13 |
| 2022-12-31 | $64.13K 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |